Advertisement

Topics

Human medicines European public assessment report (EPAR): Cinacalcet Mylan, cinacalcet, Hyperparathyroidism, Secondary,Hypercalcemia, Date of authorisation: 19/11/2015, Revision: 3, Status: Authorised

08:00 EDT 16 Apr 2019 | European Medicines Agency

Human medicines European public assessment report (EPAR): Cinacalcet Mylan, cinacalcet, Hyperparathyroidism, Secondary,Hypercalcemia, Date of authorisation: 19/11/2015, Revision: 3, Status: Authorised

Original Article: Human medicines European public assessment report (EPAR): Cinacalcet Mylan, cinacalcet, Hyperparathyroidism, Secondary,Hypercalcemia, Date of authorisation: 19/11/2015, Revision: 3, Status: Authorised

NEXT ARTICLE

More From BioPortfolio on "Human medicines European public assessment report (EPAR): Cinacalcet Mylan, cinacalcet, Hyperparathyroidism, Secondary,Hypercalcemia, Date of authorisation: 19/11/2015, Revision: 3, Status: Authorised"

Advertisement
Quick Search
Advertisement
Advertisement